U.S. federal trademark · Serial No. 79409604 · Reg. No. 7813611
Pharmaceutical, biopharmaceutical, and veterinary preparations for the treatment of cancer, particularly skin cancer, including melanoma and non-melanoma skin cancer; antibodies and antibody fragments derivatives including human monoclonal antibodies and related fragments conjugated to cytokines.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.